FMR LLC - 31 Dec 2025 SCHEDULE 13G/A Report for ZENAS BIOPHARMA INC COMMON STOCK (ZBIO)

Filing Manager
FMR LLC
Reporting Manager
FMR LLC
Symbol
ZBIO
Shares outstanding
53,512,273 shares
Disclosed Ownership
7,652,255 shares
Ownership
14%
Form type
SCHEDULE 13G/A
Filing time
05 Feb 2026, 13:43:39 UTC
Date of event
31 Dec 2025
Previous filing
08 Sep 2025

Key filing fact

FMR LLC disclosed 14% ownership in ZENAS BIOPHARMA INC COMMON STOCK (ZBIO) on 31 Dec 2025.

Key facts

  • FMR LLC filed SCHEDULE 13G/A for ZENAS BIOPHARMA INC COMMON STOCK (ZBIO).
  • Disclosed ownership: 14%.
  • Date of event: 31 Dec 2025.

Change

  • Previous schedule filing date: 08 Sep 2025.
  • Current filing was accepted on 05 Feb 2026, 13:43.

Research use

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting persons

Reporting managers (2)

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
FMR LLC 14% 7,652,255 7,651,279 0 Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries*
Abigail P. Johnson 14% 7,652,255 0 0 Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson**
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .